C-reactive protein and vulnerability to mental stress-induced myocardial ischemia

Rahman Shah1, Matthew M Burg, Aseem Vashist

  • 1Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT 06520-8017, USA.

Insights

Elevated C-reactive protein (CRP) levels are associated with a higher risk of mental stress-induced myocardial ischemia (MSI) in patients with coronary artery disease (CAD). This finding suggests CRP may serve as a risk marker for MSI events.

Area of Science:

  • Cardiology
  • Clinical Research
  • Biomarkers

Background:

  • Mental stress-induced myocardial ischemia (MSI) in stable coronary artery disease (CAD) patients predicts adverse clinical outcomes.
  • The underlying mechanisms linking MSI to poor prognosis are not fully understood.
  • C-reactive protein (CRP) is a known cardiovascular risk marker, but its association with MSI is unclear.

Purpose of the Study:

  • To investigate the relationship between serum C-reactive protein (CRP) levels and the risk of developing mental stress-induced myocardial ischemia (MSI) in patients with stable coronary artery disease (CAD).

Main Methods:

  • Eighty-three stable CAD patients underwent simultaneous myocardial perfusion imaging (MPI) using SPECT and transthoracic echocardiography (TTE) at rest and during laboratory-induced mental stress (MS).
  • Serum CRP levels were measured 24 hours post-MS.
  • MSI was diagnosed by new perfusion defects on SPECT and/or new regional wall motion abnormalities on TTE during MS.

Main Results:

  • 36% of patients (30/83) developed MSI.
  • No significant differences were observed in baseline characteristics or hemodynamic responses between patients with and without MSI.
  • Each 1 mg/L increase in CRP level was associated with a 20% increased risk of MSI (OR 1.2, 95% CI 1.01-1.39, P=.04), a finding consistent in multivariate analyses.

Conclusions:

  • Serum CRP levels may serve as a predictive risk marker for mental stress-induced myocardial ischemia (MSI) in patients with coronary artery disease (CAD).
  • Further research is warranted to elucidate the pathophysiological link between CRP and MSI.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...